GL1X · GenesisL1 explorer

MolNFT v1 · #31099 · protein

Crystal structure of the editing domain of E. COLI leucyl-tRNA synthetase complexes with isoleucine

2AJI: “Crystal structure of the editing domain of E. COLI leucyl-tRNA synthetase complexes with isoleucine”. X-ray diffraction, 1 ligand (ILE), 4 pockets (best druggability 0.61). MolNFT v1 #31099 on GenesisL1: 3D structure, binding sites…

PDB
2AJI
Type
protein
Length
361 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Leucyl-tRNA synthetase
EC
6.1.1.4
UniProt
P07813
Ligands
ILE
Pockets
4 · best druggability 0.61

Structure

x-ray diffraction · 2 distinct chains · 29% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALeucyl-tRNA synthetase (EC 6.1.1.4)protein18629% helix, 24% strandP07813
BLeucyl-tRNA synthetase (EC 6.1.1.4)protein17528% helix, 25% strandP07813

Ligands and binding sites

  • ILE · Isoleucine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13120.610.7829ILE
21750.490.7723ILE
3690.400.7914empty
4730.370.7821empty

Interfaces

1 interface between chains.

  • A–B · 622 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 2AJI · Crystal structure of the editing domain of E. coli leucyl-tRNA synthetase complexes with… · the same entry in another collection · chain A against A, TM-score 1.00
  • P07813 · AlphaFold monomer V2.0 prediction for leucine--tRNA ligase (P07813) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.